SCHEMBL6674722

SCHEMBL6674722

COc1ccc(C(=O)CC(Cc2ccc(Cl)cc2)C(=O)O)cc1.O=C(CC(Cc1ccccc1)C(=O)O)c1ccc2ccccc2c1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.57
KMT2A Q03164 1/20 0.56
BCL2L1 Q07817 1/20 0.50
MCL1 Q07820 1/20 0.50
MGAM O43451 2/20 0.47
GAA P10253 2/20 0.47
SI P14410 2/20 0.47
MGAM2 Q2M2H8 2/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 1/20 0.45
PPARG P37231 5/20 0.44
PPARA Q07869 4/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671105 0.97 KMO (0.54) KMOKMT2ABCL2L1MCL1MGAM
SCHEMBL6674727 0.92 KMT2A (0.47) KMOKMT2ABCL2L1MCL1MGAM
SCHEMBL6662270 0.92 KMT2A (0.48) KMOKMT2ABCL2L1MCL1MGAM
SCHEMBL3104154 0.89 KMT2A (0.68) KMOKMT2ABCL2L1MCL1ALDH1A1
SCHEMBL16284888 0.85 NPC1 (0.60) KMOKMT2ANPC1RAB9APPARG
SCHEMBL3101828 0.85 NPC1 (0.60) KMOKMT2ANPC1RAB9APPARG
SCHEMBL6672877 0.85 NPC1 (0.60) KMOKMT2ANPC1RAB9APPARG
SCHEMBL16284887 0.85 NPC1 (0.60) KMOKMT2ANPC1RAB9APPARG
SCHEMBL3104413 0.84 KMO (0.68) KMOPPARGPPARA
SCHEMBL9554501 0.82 KMO (0.72) KMOBCL2L1MCL1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458412-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GmbH (DE) 2004-09-22 EP claimed
WO-2003055523-A1 PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GMBH (DE) 2003-07-10 WO claimed